Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Curr Opin HIV AIDS. 2017 Jul;12(4):343–350. doi: 10.1097/COH.0000000000000374

Table 1. Novel Approaches to Universal ART.

Antiretroviral Drugs
Less Frequent Administration of Current Oral Drugs
  Tenofovir
  Efavirenz
New Orally Administered Drug
  EFdA (MK-8591)
Long-Acting Injectables
  Carbotegravir
  Rilpivirine
Polymer Implants
  Tenofovir
  EFdA (MK-8591)
Monoclonal Antibodies
Broadly Neutralizing Antibodies
  VRC01, VRC01-LS
  3BNC117
  10-1074
Antibodies that Inhibit Cell Entry
  Ibalizumab
  PRO 140